Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
复制标题
DOI:
10.1186/s12974-019-1440-5
复制
发表时间:
2019-03-11
影响因子:
9.3
通讯作者:
Asgari, N.
中科院分区:
文献类型:
--
作者:
Olesen, M. N.;Soelberg, K.;Asgari, N.
BackgroundLong-term outcome in multiple sclerosis (MS) depends on early treatment. In patients with acute optic neuritis (ON), an early inflammatory event, we investigated markers in cerebrospinal fluid (CSF), which may predict a diagnosis of MS.MethodsForty patients with acute ON were recruited in a prospective population-based cohort with median 29months (range 19-41) of follow-up. Paired CSF and serum samples were takenwithin 14days (range 2-38), prior to treatment. Prospectively, 16/40 patients were by a uniform algorithm diagnosed with MS (MS-ON) and 24 patients continued to manifest isolated ON (ION) during follow-up. Levels of cytokines and neurofilament light chain (NF-L) were measured at the onset of acute ON and compared to healthy controls (HC). Significance levels were corrected for multiple comparisons (q). The predictive value of biomarkers was determined with multivariable prediction models using nomograms.ResultsCSF TNF-, IL-10, and CXCL13 levels were increased in MS-ON compared to those in ION patients (q=0.021, 0.004, and 0.0006, respectively). MS-ON patients had increased CSF pleocytosis, IgG indices, and oligoclonal bands (OCBs) compared to ION (q=0.0007, q=0.0058, and q=0.0021, respectively). CSF levels of IL-10, TNF-a, IL-17A, and CXCL13 in MS-ON patients correlated with leukocyte counts (r>0.69 and p0.55, p